A genetic test developed by researchers at Broad Clinical Labs and the U.S. Department of Veterans Affairs (VA) is now enabling a large, nationwide clinical trial aimed at improving health care for ...

Does Sexual Activity Influence Prostate Diseases or Does Excessive Sex Have an Impact? Sexual activity can influence prostate health, but the impact varies depending on the type of prostate condition ...

BEAVERTON, OR, UNITED STATES, January 13, 2026 /EINPresswire.com/ — Sedia Biosciences Corporation, a leading developer of innovative diagnostic tests for infectious ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment. A recent ...

Wolinsky is a Chicago-based medical journalist and publisher of The Active Surveillor, a Substack newsletter that covers lower-risk prostate cancer and active surveillance. In 2002, at age 55, I ...

NEW YORK – Infectious disease diagnostics developer Sedia Biosciences announced on Tuesday that the World Health Organization has granted prequalification status for the firm's rapid, oral fluid HIV ...

NEW YORK – Mdxhealth and the University of Oxford will test whether the firm's Genomic Prostate Score (GPS) assay can predict disease progression and treatment outcomes in prostate cancer patients, ...

NASHVILLE, Tenn. (WSMV) - A new Tennessee law taking effect Thursday increases penalties for repeat DUI offenders and gives law enforcement officers a new roadside testing tool to screen for drugs.

IsoPSA offers a more precise prostate cancer screening by analyzing PSA protein isoforms, reducing false positives compared to traditional PSA tests. Clinical studies show IsoPSA's superior diagnostic ...

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for prostate-specific antigen, known as a PSA test. The IsoPSA blood test, developed by ...